NHLTYNIGHTINGALE HEALTH OYJ

About NIGHTINGALE HEALTH OYJ (NHLTY)

NIGHTINGALE HEALTH OYJ (NHLTY) is a N/A company headquartered in Helsinki, Finland whose shares trade over-the-counter on the OTCQX tier.

Nightingale Health's mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world's most advanced health check that provides risk detection for multiple chronic diseases from a single blood sample. Nightingale Health Check can be scaled to entire populations at a low cost, and it can replace many of the current clinical risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases. With every sample we help to create a healthier world. Nightingale Health operates globally with a parent company in Finland and eight subsidiaries in countries such as Japan, the United States, Singapore, and the United Kingdom. Nightingale Health has customers in more than 34 countries in the healthcare and medical research sectors. The company's technology is being used in many of the world's leading health initiatives, such as the UK Biobank, and over 600 peer-reviewed publications validate the technology.

Products and services

Nightingale Health Check detects the risks associated with various common chronic diseases from a single blood sample, requiring only age and sex as clinical parameters. This represents a significant simplification compared to current risk assessments, which typically address one disease risk at a time and require numerous independent data points, such as individual blood values, clinical examinations and patient questionnaires. Nightingale Health Check presents the health industry with a transformative opportunity to replace current routine risk tests with a solution that makes impactful prevention of chronic diseases a reality.

NHLTY key facts

Ticker symbol

NHLTY

Market tier

OTCQX

Headquarters

Helsinki, Finland

Country of incorporation

FI

Year of incorporation

2002

Employees

86

Shares outstanding

40,296,821

Reporting standard

International Reporting: NASDAQ Helsinki

Audit status

Audited

Fiscal year end

6/30

Latest filing

Semi-Annual Report (Dec 31, 2024)

NIGHTINGALE HEALTH OYJ leadership

• Teemu Pentti Suna — CEO
• Satu Sinikka Saksman — COO
• Tuukka Tapani Paavola — CFO
• Antti Juhana Kangas — CTO
• Minja Karoliina Salmio — Chief Legal Officer
• Jeffrey Charles Barrett — Chief Scientific Officer
• Salla Tellervo Ruosaari — Research & Development
• Maria Kanno — Controller

Explore more: OTCQX stocks · OTC stocks starting with N